Cargando…
Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioning
AIMS: Alzheimer's disease (AD) and type 2 diabetes (T2D) are two of the most common diseases in elderly population and they have a high rate of comorbidity. Study has revealed that T2D is a major risk factor of AD, and thus exploring therapeutic approaches that can target both diseases has draw...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580347/ https://www.ncbi.nlm.nih.gov/pubmed/37183545 http://dx.doi.org/10.1111/cns.14260 |